When patients receiving anticoagulation therapy undergo invasive procedures,
management requires an individualized assessment of the risk of bleeding versus the risk of …

Chronic kidney disease, defined as a reduced glomerular filtration rate or increased urinary
albumin excretion, is recognised as a rapidly growing global health burden, and increasing …

Patients with ischemic stroke or transient ischemic attack and non-valvular atrial fibrillation
have a high risk of recurrent stroke and other vascular events. The aim of this guideline is to …

Patients with chronic kidney disease and end-stage renal disease are at 5-to 10-fold higher
risk for developing cardiovascular disease (CVD) than age-matched controls. Clinically …

Patients with chronic kidney disease (CKD) are at high risk to develop cardiovascular
disease with its manifestations coronary artery disease, heart failure, arrhythmias, and …

Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …

Novel oral anticoagulants (NOACs)(rivaroxaban, dabigatran, apixaban) have been
approved by international regulatory agencies to treat atrial fibrillation and venous …

Chronic kidney disease (CKD) is prevalent in elderly patients with atrial fibrillation and is an
independent risk factor for stroke. Warfarin anticoagulation is efficacious for stroke …

ABSTRACT BACKGROUND Calciphylaxis, a rare disease seen in chronic dialysis patients,
is associated with significant morbidity and mortality. As is the case with other rare diseases …

Importance Levels of fibroblast growth factor 23 (FGF23) are elevated in chronic kidney
disease (CKD) and strongly associated with left ventricular hypertrophy, heart failure, and …